NELARABINE for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 83 adverse event reports in the FDA FAERS database where NELARABINE was used for Product used for unknown indication.
Most Reported Side Effects for NELARABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 67 | 9.1% | 6 | 40 |
| Drug ineffective | 50 | 6.8% | 14 | 10 |
| Myelopathy | 47 | 6.4% | 3 | 8 |
| Neurotoxicity | 47 | 6.4% | 10 | 14 |
| Neuropathy peripheral | 45 | 6.1% | 5 | 18 |
| Muscular weakness | 42 | 5.7% | 6 | 14 |
| Sepsis | 39 | 5.3% | 17 | 15 |
| Peripheral sensory neuropathy | 38 | 5.2% | 3 | 7 |
| Neutropenia | 37 | 5.0% | 8 | 10 |
| Off label use | 37 | 5.0% | 5 | 6 |
| Respiratory failure | 34 | 4.6% | 25 | 13 |
| Guillain-barre syndrome | 32 | 4.4% | 15 | 13 |
| Polyneuropathy | 29 | 4.0% | 1 | 5 |
| Malignant neoplasm progression | 28 | 3.8% | 17 | 6 |
| Hypoaesthesia | 27 | 3.7% | 1 | 13 |
Other Indications for NELARABINE
T-cell type acute leukaemia (238)
Acute lymphocytic leukaemia (185)
Non-hodgkin's lymphoma (47)
Precursor t-lymphoblastic lymphoma/leukaemia (47)
T-cell lymphoma (18)
Acute lymphocytic leukaemia recurrent (14)
Precursor t-lymphoblastic lymphoma/leukaemia refractory (12)
Chemotherapy (10)
Adult t-cell lymphoma/leukaemia (8)
Precursor t-lymphoblastic leukaemia acute (7)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)